Key result
Roux-en-Y gastric bypass yields ~10% more 5-year excess weight loss than sleeve gastrectomy but increases readmissions.
Why the study?
Robust data on quality of life after different techniques of bariatric surgery are sparse.
Does Roux-en-Y gastric bypass improve excess weight loss compared to sleeve gastrectomy in obese patients?
RCT (n=100)
randomly assigned
Does Roux-en-Y gastric bypass improve excess weight loss compared to sleeve gastrectomy in obese patients?
Roux-en-Y gastric bypass provides more stable long-term weight loss than sleeve gastrectomy but is associated with higher readmission rates and longer hospital stays.
Answers are grounded in this paper and cite their sources.
Similar long-term QoL after sleeve and RYGB; leaves open procedure selection by GERD risk in Level 3 data.
BACKGROUND: Robust data on quality of life (QoL) after different techniques of bariatric surgery are sparse. This RCT compared excess weight loss (EWL) and QoL after sleeve gastrectomy versus Roux-en-Y gastric bypass (RYGB). METHODS: Obese patients were assigned randomly to RYGB or sleeve gastrectomy. The primary outcome measure was EWL. Secondary outcomes included QoL, co-morbidity, adverse events, vitamin and glycolipid status. QoL was assessed before and annually after surgery, using the Moorehead-Ardelt Quality of Life Questionnaire II (M-A-QoLQII) and Gastrointestinal Quality of Life Index (GIQLI). RESULTS: One hundred patients were enrolled, 45 in the RYGB group and 55 in the sleeve gastrectomy group. Mean postoperative EWL at 1, 2, 3 and 5 years was 80·4, 79·8, 83·0 and 74·8 per cent respectively after RYGB, and 83·0, 77·8, 66·3 and 65·1 per cent after sleeve gastrectomy (P = 0·017). Mean M-A-QoLQII score before surgery and at 1, 2, 3 and 5 years after operation was 0·5, 1·6, 1·7, 2·1 and 1·4 respectively after RYGB, and 0·3, 1·7, 1·5, 1·5 and 1·2 after sleeve gastrectomy. Mean GIQLI score before and at 1, 2, 3, 5 years after RYGB was 96·4, 113·8, 113·3, 113·4, 111·7, compared with 90·7, 113·9, 114·5, 113·1 and 113·0 for sleeve gastrectomy. The improvement was significant compared with preoperative values (P < 0·001 for M-A-QoLQII and GIQLI), with no difference between groups (P = 0·418 and P = 0·323 respectively). RYGB resulted in higher readmission rates (P = 0·002) and length of hospital stay (P = 0·006) than sleeve gastrectomy. CONCLUSION: RYGB and sleeve gastrectomy resulted in equivalent, long-standing QoL improvement. RYGB resulted in more stable weight loss but was associated with higher readmission rates. Registration number: NCT02475590.
No takes yet. Share an insight, caveat, or question.
Ignat et al. (2016) conducted an RCT in Obesity (n=100). Roux-en-Y gastric bypass vs. sleeve gastrectomy was evaluated on excess weight loss (EWL) (p=0.017). Roux-en-Y gastric bypass yielded greater 5-year excess weight loss than sleeve gastrectomy but had higher readmission rates and longer hospital stays.
Synapse has enriched 10 related papers. Consider them for comparative context: